Per Niklas Arnberg
Gründer bei Adenovir Pharma AB
Profil
Per Niklas Arnberg is the founder of Adenovir Pharma AB, which was founded in 2007, where he holds the title of Director.
He is currently employed at Umea Universitet as a Professor in the Virology Department.
Aktive Positionen von Per Niklas Arnberg
| Unternehmen | Position | Beginn |
|---|---|---|
Adenovir Pharma AB
 Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Gründer | 11.12.2007 |
| Umea Universitet | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Adenovir Pharma AB
Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |